YSB (HKG:9885) granted over 2.5 million award shares to 415 employees on Tuesday under a 2023 incentive scheme, according to a same-day Hong Kong bourse filing.

The shares represent 0.37% of the pharmaceutical retailer's issued share capital.

The firm now has 45.5 million shares available for future grant under the scheme mandate limit and 1.1 million shares available under the service provider sublimit.